# A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis

> **NCT03630939** · PHASE1,PHASE2 · COMPLETED · sponsor: **Escalier Biosciences B.V.** · enrollment: 104 (actual)

## Conditions studied

- Psoriatic Plaque

## Interventions

- **DRUG:** ESR-114
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03630939
- **Lead sponsor:** Escalier Biosciences B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-09
- **Primary completion:** 2019-06-05
- **Final completion:** 2019-06-12
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2020-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03630939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03630939, "A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT03630939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*